NCT05951127View on ClinicalTrials.gov

Additional Consolidative Esophagectomy for the Patients With Oligometastatic Resectable ESCC

NAActive, not recruitingINTERVENTIONAL
Enrollment

141

Participants

Timeline

Start Date

November 1, 2022

Primary Completion Date

October 31, 2027

Study Completion Date

October 31, 2027

Conditions
Esophageal Squamous Cell CarcinomaOligometastatic Disease
Interventions
PROCEDURE

Esophagectomy

Esophagectomy for esophageal cancer and regional lymph nodes dissection.

Trial Locations (2)

100021

Cancer Hospital Chinese Academy of Medical Sciences, Beijing

National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing

All Listed Sponsors
lead

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

OTHER